Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-κB Mutations or Activation of the CD30, CD40, and RANK Receptors
Bei Zheng(The University of Texas MD Anderson Cancer Center), Anas Younes(Memorial Sloan Kettering Cancer Center)
Cited by 109
Related Papers
The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells
|Blood|2008|103
The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma
|Blood Cancer Journal|2011|70
Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
|Oncotarget|2017|67